SCHEMBL27693249

SCHEMBL27693249

O=COC1(NC(=O)c2cc(F)c3ccccc3c2OCc2ccc(C(F)(F)F)cn2)CCC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 3/20 0.43
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALOX5AP P20292 1/20 0.35
FGFR4 P22455 2/20 0.35
MAPKAPK2 P49137 1/20 0.34
HCRTR1 O43613 4/20 0.34
RPS6KA3 P51812 1/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 2/20 0.34
HCRTR2 O43614 1/20 0.34
PDE2A O00408 3/20 0.33
DHODH Q02127 1/20 0.33
SLC6A9 P48067 1/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27712979 0.88 CXCR2 (0.53) CXCR2
SCHEMBL485695 0.86 CXCR2 (0.56) CXCR2ALDH1A1SMN1; SMN2NPSR1ALOX5AP
SCHEMBL485478 0.85 CXCR2 (0.56) CXCR2ALDH1A1SMN1; SMN2NPSR1ALOX5AP
Formic Acid SCHEMBL27693250 0.81 MRGPRX4 (0.43) HCRTR1HCRTR2POLBMAPT
SCHEMBL485687 0.80 MRGPRX4 (0.45) ALOX5APHCRTR1HCRTR2POLBMAPT
SCHEMBL485799 0.80 MRGPRX4 (0.45) HCRTR1HCRTR2POLBMAPT
SCHEMBL27693416 0.79 CXCR2 (0.38) CXCR2ALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL27693267 0.79 CXCR2 (0.43) CXCR2
SCHEMBL12467343 0.78 CXCR2 (0.39) CXCR2ALDH1A1RPS6KA3KDM4EHPGD
SCHEMBL27693232 0.77 CXCR2 (0.45) CXCR2SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN claimed
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN disclosed